FSA
OrganizationRelationship Network
Event Timeline
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2019-01-01 | N/A | UK Food Standards Agency (FSA) announced investigation of CBD products. | UK | View |
| 2011-11-16 | N/A | FSA claimed an attack on an army convoy. | Near Deraa | View |
| 2011-11-16 | N/A | FSA attacked the headquarters of the Air Force Intelligence Agency. | Harasta | View |
EFTA00027419.pdf
This document is an email dated September 10, 2021, from a Fact Witness Coordinator at the U.S. Attorney's Office (SDNY) to a redacted recipient (likely a witness). The email provides travel logistics, including a flight itinerary (attached as VVQERK.pdf) and instructions for Delancey Car Service (Confirmation # 758261) to transport the individual to a hotel and subsequent meeting. The document appears to be related to legal proceedings occurring in 2021, potentially the Ghislaine Maxwell trial given the SDNY context.
HOUSE_OVERSIGHT_026922.jpg
This document is a legal disclaimer page (page 14) from a Goldman Sachs presentation or report, bearing the Bates stamp HOUSE_OVERSIGHT_026922, indicating it was part of a US Congressional investigation. It details regulatory compliance, licensing exemptions, and restrictions for distributing financial materials in various jurisdictions including Australia, Brazil, Chile, Dubai, Israel, Singapore, and the UAE. It specifically notes that Goldman Sachs entities are not licensed to provide investment advice in Israel and outlines 'wholesale client' restrictions in Australia.
HOUSE_OVERSIGHT_026907.jpg
This document contains legal disclaimers and regulatory disclosures regarding financial services provided by Goldman Sachs entities across multiple jurisdictions, including Australia, Brazil, Chile, Dubai, and Israel. It specifies the regulatory bodies governing operations in each region, outlines restrictions on who may receive the materials (e.g., wholesale clients, sophisticated investors), and clarifying licensing exemptions.
HOUSE_OVERSIGHT_023159.jpg
This document is a page from a chronology (page xxvii), likely from an academic book published by Oxford University Press in 2014, found within a House Oversight dataset. It details major geopolitical events in the Middle East between June 2007 and September 2011, focusing on the Israeli-Palestinian conflict, Lebanese politics, and the Arab Spring uprisings in Egypt and Syria. The text lists changes in leadership, military conflicts (such as Operation Cast Lead), UN resolutions, and diplomatic agreements.
HOUSE_OVERSIGHT_013927.jpg
This document appears to be a page from a business strategy book or operational manual (resembling Tim Ferriss's 'The 4-Hour Workweek') included in a House Oversight Committee evidence dump. It provides specific instructions for scaling a business's shipping fulfillment operations from 'Phase II' (>10 units/week) to 'Phase III' (>20 units/week), including tactics for negotiating fees, vetting vendors, and setting up call centers. While marked with a House Oversight Bates stamp, the text itself contains no direct references to Epstein, specific individuals, or illicit activities.
HOUSE_OVERSIGHT_025060.jpg
This page appears to be a page from a briefing document or news summary (marked with House Oversight Bates stamp 025060). The text includes an excerpt discussing the Syrian Civil War, specifically the fragmentation of the FSA and a recommendation to create elite forces to secure chemical weapons. The bottom of the page lists 'Article 5,' a piece from Foreign Policy magazine by Matthew Levitt titled 'Why Does Europe Pretend Hezbollah Has a Good Side?'
HOUSE_OVERSIGHT_024897.jpg
This document is page 81 of a Cowen Collaborative Insights market research report dated February 25, 2019, discussing the regulatory landscape for medical cannabis and CBD in Europe, specifically the UK and Italy. It details the legalization history, licensing requirements involving agencies like the MHRA and FSA, and market activities of companies like GW Pharmaceuticals, Tilray, Bedrocan, Canopy, and Aurora. The document bears a 'HOUSE_OVERSIGHT_024897' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024112.jpg
This document is page 101 of a confidential offering memorandum detailing legal disclaimers and regulatory compliance for an investment fund across multiple jurisdictions (Brazil, Columbia, Denmark, Finland). It specifically notes that the entity 'New Leaf' is involved in the transaction, stating that recipients contacted New Leaf on their own initiative. The footer indicates this document is part of a House Oversight Committee investigation (CONTROL NUMBER 257).
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity